• Product NameQuinoline, 6-(bromomethyl)- (6CI,9CI)
  • CasNo. 101279-39-4
  • MFC10H8BrN
  • MW222.084
  • Purity
  • Appearance
  • Packing
  • Contact usInquiry

Product Details

CasNo: 101279-39-4

MF: C10H8BrN

Offer Chemical Raw Material Quinoline, 6-(bromomethyl)- (6CI,9CI) 101279-39-4 In Stock

  • Molecular Formula:C10H8BrN
  • Molecular Weight:222.084
  • Vapor Pressure:0.000544mmHg at 25°C 
  • Melting Point:74-75℃ 
  • Refractive Index:1.673 
  • Boiling Point:321.9 °C at 760 mmHg 
  • PKA:4.62±0.10(Predicted) 
  • Flash Point:148.5 °C 
  • PSA:12.89000 
  • Density:1.518 g/cm3 
  • LogP:3.12970 

Quinoline, 6-(bromomethyl)- (6CI,9CI)(Cas 101279-39-4) Usage

General Description

Quinoline, 6-(bromomethyl)- (6CI,9CI) is a chemical compound categorized under the class of organic compounds known as quinolines and derivatives. Quinolines are compounds containing quinoline, a specific aromatic heterocycle that is structurally characterized by a 2-phenyl-1-benzazepine moiety. Few characteristics of this chemical are its light yellow appearance, low to medium water solubility, and strong acidic nature. Quinoline, 6-(bromomethyl)- (6CI,9CI) is quite reactive and because of this, it is widely used in the synthesis of various chemical products, particularly some pharmaceuticals and dyes. However, due to its potential toxicity, careful handling and adequate protective measures are necessary during its usage.

InChI:InChI=1/C10H8BrN/c11-7-8-3-4-10-9(6-8)2-1-5-12-10/h1-6H,7H2

101279-39-4 Relevant articles

Design, synthesis, and LFA-1/ICAM-1 antagonist activity evaluation of Lifitegrast analogues

An, Yuanlong,Du, Guoxin,Du, Weiwei,Gong, Qi,Hao, Feifei,He, Wei,He, Xiangdong,Jiang, Hualiang,Tong, Xiaochu,Wang, Minnan,Zhang, Donglei,Zheng, Mingyue

, (2022/02/22)

The interaction between Lymphocyte funct...

THERAPEUTIC COMPOUNDS AND METHODS TO TREAT INFECTION

-

Paragraph 0464-0465, (2019/02/13)

Disclosed herein are compounds of formul...

CYTOTOXIC PEPTIDES AND ANTIBODY DRUG CONJUGATES THEREOF

-

Page/Page column 217, (2013/06/05)

The present invention is directed to cyt...

CYTOTOXIC PEPTIDES AND ANTIBODY DRUG CONJUGATES THEREOF

-

Page/Page column, (2013/06/04)

The present invention is directed to cyt...

101279-39-4 Process route

6-(hydroxymethyl)quinoline
100516-88-9

6-(hydroxymethyl)quinoline

6-bromomethyl quinoline
101279-39-4

6-bromomethyl quinoline

Conditions
Conditions Yield
With hydrogen bromide; acetic acid; at 20 ℃; for 3h;
37.5%
With hydrogen bromide; acetic acid;
With water; hydrogen bromide; at 130 ℃;
6-(hydroxymethyl)quinoline; With phosphorus tribromide; In benzene; at 60 ℃; for 0.75h;
With water; sodium hydrogencarbonate; In benzene;
With phosphorus tribromide; In dichloromethane; at 20 ℃;
6-methylquinoline
91-62-3

6-methylquinoline

6-bromomethyl quinoline
101279-39-4

6-bromomethyl quinoline

Conditions
Conditions Yield
With N-Bromosuccinimide; 2,2'-azobis(isobutyronitrile); In tetrachloromethane; for 2h; Reflux;
72.6%
With N-Bromosuccinimide; dibenzoyl peroxide; In tetrachloromethane; for 2h; Heating;
With N-Bromosuccinimide; dibenzoyl peroxide; In tetrachloromethane; for 3h; Reflux;

101279-39-4 Upstream products

  • 100516-88-9
    100516-88-9

    6-(hydroxymethyl)quinoline

  • 91-62-3
    91-62-3

    6-methylquinoline

  • 128-08-5
    128-08-5

    N-Bromosuccinimide

  • 4113-04-6
    4113-04-6

    quinoline-6-carbaldehyde

101279-39-4 Downstream products

  • 212770-17-7
    212770-17-7

    2-(4-methoxy-benzenesulfonyl)-2-methyl-3-quinolin-6-yl-propionic acid ethyl ester

  • 1051315-52-6
    1051315-52-6

    6-phenyl-2-(quinolin-6-ylmethyl)pyridazin-3(2H)-one

Relevant Products